毛志强 教授

作者:

编辑:

来源:威廉williamhill官网

发布日期:2022年12月29日 12:32

阅读:

28BEA

一、基本信息:

毛志强,教授,博士生导师,生物医学工程系,省级人才。

二、联系方式:

邮箱:maozq@hubu.edu.cn

三、教育与工作经历:

2024.10—至今 威廉希尔中国官网 威廉williamhill官网,教授

2022.3—2023.3韩国高丽大学(Korea University) 化学系,访问学者

2019.7-2024.9威廉希尔中国官网化学化工学院、威廉williamhill官网,副教授

2018.2—2019.6 威廉希尔中国官网 化学化工学院,讲师

2017.7—2018.1 中南民族大学,研究助理

2012.9—2017.6 武汉大学,博士,分析化学

四、研究方向

研究方向聚焦于近红外分子荧光探针的研制及活体脑成像分析,包括脑部分子影像,脑疾病的分子诊疗,药物合成和开发等领域,主持国家自然科学基金项目2项、湖北省自然科学基金项目1项,以第一作者(含共同通讯作者)在Nat. Commun., Angew. Chem. Int. Ed. (2篇), Matter, Adv. Funct. Mater., Advanced Science, Analytical Chemistry (5篇), Chemical Science (3篇)等学术刊物发表SCI论文40余篇,教学研究论文2篇,申请专利5项;担任Journal of Analysis and Testing等学术期刊青年编委。

五、教学情况

本科生:《无机及分析化学》,《生物医学光子学》,《生物医学工程导论》等

研究生:《新药研究与开发》等

六、科研项目与成果

科研项目:

1. 国家自然科学基金面上项目,项目批准号:22174034,2022-01至2025-12,主持。

2. 国家自然科学基金青年项目,项目批准号:21804033,2019-01至2021-12,主持。

3. 湖北省自然科学基金面上项目,项目批准号:2021CFB305,2021-10至2023-09,主持。

4. 威廉希尔中国官网原创探索种子专项,2026-01至2027-12,主持。

5. 湖北省“楚天学者-楚天学子”人才项目,2019-02至2024-01,主持。

代表成果:

1.Miantai Ye, Xiaoyu Wang, Jingwen Zou, Wei Sun, Weijie Chi,*Zhiqiang Mao,* Zhihong Liu,* Breaking shackles of molecular weight and emission for NIR-II fluorophores by regulating Columb attraction interaction,Nature Communications, 2025, 16, 8007. (SCI一区,IF=15.7)

2.Jiankang Gong, Xiaoyu Wang, Jiao Wu, Changyu Yoon, Yujin Kim, Jingwen Zou,Zhiqiang Mao,*Jong Seung Kim,*Diaminonaphthalene Boronic Acid (DANBA): New Approach for Peroxynitrite Sensing Site.Angew. Chem. Int. Ed. 2024,63,e202409295. (SCI一区,IF=16.1)

3.Pengzhang Wang, Le Yu, Jiankang Gong, Jianhua Xiong, Soyu Zi, Hua Xie, Fan Zhang,Zhiqiang Mao,* Zhihong Liu,* Jong Seung Kim.* An Activity-Based Fluorescent Probe for Imaging Fluctuations of Peroxynitrite (ONOO-) in the Alzheimer's Disease Brain.Angew. Chem. Int. Ed.2022,61,e202206894. (SCI一区,IF=16.823)

4.Jianhua Xiong, Pengzhan Wang, Subin Son, Zhong Cheng, Fan Zhang,Zhiqiang Mao,* Zhihong Liu,* Jong Seung Kim.* Engineering a theranostic platform for synergistic hypoxia-responsive photodynamic therapy and chemotherapy.Matter2022, 5, 1502-1519. (SCI一区, IF=19.967)

5.Zhiqiang Mao, Hyeonji Rha, Jungryun Kim, Xinru You, Fan Zhang,*Wei Tao,*Jong Seung Kim.*THQ–Xanthene: An Emerging Strategy to Create Next-Generation NIR-I/II Fluorophores.Advanced Science, 2023, 10, 2301177. (SCI一区, IF=17.521)

6.Xiaoyu Wang, Jingwen Zou, Yixuan Tao, Zhiwen Zhou, Changyu Bian, Zhiqiang Mao,* Zhihong Liu,* PROTAC-Powered Synergistic Tumor Therapy,Trends in Analytical Chemistry, 2026, 196, 118678. (SCI一区,IF=12.0)

7.Jianhua Xiong, Xiaoyu Wang, Jaewon Kim, Jiankang Gong,Zhiqiang Mao,* Jong Seung Kim,* Zhihong Liu.* Tumor-Activated Prodrug with Synergistic Anti-Stemness Chemical and Photodynamic Therapies.Advanced Functional Materials, 2024, 34,2312590. (SCI一区,IF=19.0)

8.Jianhua Xiong, Weijie Chi, Miantai Ye, Li Zhang, Xiaoyu Wang,Zhiqiang Mao,* and Zhihong Liu.* Activatable Phototherapeutic Prodrug Conquering Hypoxia Limitation to Enhance Chemical Drug Delivery Efficiency.ACS Materials Letters2024, 6, 2548−2558. (SCI一区,IF=11.4)

9.Xiaoyu Wang, Jiankang Gong, Jiaxuan Wang, Fan Zhang, Zhiqiang Mao*,Zhihong Liu*. Engineering molecular theranostic probes for antibaterial therapy.Trends in Analytical Chemistry, 2023, 167, 117232. (SCI一区, IF=13.1)

10.Maintai Ye, Yunhui Xiang, Jiankang Gong, Xiaoyu Wang, Zhiqiang Mao,* Zhihong Liu.* Monitoring Hg2+and MeHg+Poisoning in Living Body with An Activatable Near-infrared II Fluorescence Probe,Journal of Hazardous Materials, 2023, 445, 130612. (SCI一区,IF=14.224)